Cargando…
Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286330/ https://www.ncbi.nlm.nih.gov/pubmed/35634752 http://dx.doi.org/10.1002/clc.23851 |
| _version_ | 1784747986062934016 |
|---|---|
| author | Deng, Jian‐Hao Zhang, Jia‐Xing |
| author_facet | Deng, Jian‐Hao Zhang, Jia‐Xing |
| author_sort | Deng, Jian‐Hao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9286330 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92863302022-07-19 Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis Deng, Jian‐Hao Zhang, Jia‐Xing Clin Cardiol Letter to the Editor John Wiley and Sons Inc. 2022-05-30 /pmc/articles/PMC9286330/ /pubmed/35634752 http://dx.doi.org/10.1002/clc.23851 Text en © 2022 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Deng, Jian‐Hao Zhang, Jia‐Xing Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis |
| title | Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis |
| title_full | Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis |
| title_fullStr | Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis |
| title_full_unstemmed | Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis |
| title_short | Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis |
| title_sort | comment on: cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: a systematic and meta‐analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286330/ https://www.ncbi.nlm.nih.gov/pubmed/35634752 http://dx.doi.org/10.1002/clc.23851 |
| work_keys_str_mv | AT dengjianhao commentoncardiovascularsafetyoffebuxostatcomparedtoallopurinolforthetreatmentofgoutasystematicandmetaanalysis AT zhangjiaxing commentoncardiovascularsafetyoffebuxostatcomparedtoallopurinolforthetreatmentofgoutasystematicandmetaanalysis |